According to the American Cancer Society, the average American man has a 1 in 726 chance of getting diagnosed with breast ...

The results of a clinical trial published last month targeted breast cancer "sleeper cells," which are cells that break away from the main tumor and can resurface later to spread cancer throughout the ...

“The long-term outcomes from CheckMate 238 confirm that nivolumab is a proven adjuvant treatment for patients with melanoma at high risk for recurrence, with sustained improvement in recurrence-free ...

A machine learning model may be a valid method of determining the risk for recurrence of MS among individuals who discontinue ...

Aaron Broverman is the Managing Editor of Forbes Advisor Canada. He has almost 20 years of experience writing in the personal finance space for outlets such as Bankrate, Bankrate Canada, ...

Breast cancer recurrence does happen, but thankfully the chance of it is low. Recurrence depends on factors like the type and ...